LARC Robotics: Spin-off from Interventional Systems (CEO Pedro Costa); focused on simplifying percutaneous renal access in PCNL for kidney stones. CE-marked/FDA-cleared for 2D/3D fluoroscopy-guided procedures; clinical validation ongoing (e.g., first robotic-assisted PCNL cases in Austria; studies like NCT07211555). Expanding to ultrasound guidance/digital platform. Still in development/early clinical; procedures undisclosed (early adoption). Stealth/undisclosed funding; revenue $0. Urology (percutaneous renal access in PCNL for kidney stones)
Leave a comment